We report the characterization of a 14 kDa degradation fragment from recombinant human tumour necrosis factor-alpha (TNF alpha) by N-terminal sequencing and mass spectrometry. A single site between the dibasic residues Arg(31)-Arg(32) of the mature recombinant 17 kDa protein has been identified as the target site that generates the 14 kDa fragment. The observation that a maximum of 33% degradation occurs suggests that only one monomer per TNF trimer is cleaved. E. coli proteases specific for dibasic residues are thought to be responsible for this cleavage. A strategy has been developed which completely inhibits proteolysis. This strategy has been used to reduce the 14 kDa degradation fragment obtained from approximately 33% of the total purified protein to zero.
机构:
F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLANDF HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND
LOETSCHER, H
STUEBER, D
论文数: 0引用数: 0
h-index: 0
机构:
F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLANDF HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND
STUEBER, D
BANNER, D
论文数: 0引用数: 0
h-index: 0
机构:
F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLANDF HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND
BANNER, D
MACKAY, F
论文数: 0引用数: 0
h-index: 0
机构:
F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLANDF HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND
MACKAY, F
LESSLAUER, W
论文数: 0引用数: 0
h-index: 0
机构:
F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLANDF HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,PRTB,BLDG 15-40,CH-4002 BASEL,SWITZERLAND